Xinli Wang
Fujian Medical University Union Hospital, No. 29 Xinquan Street
Fuzhou, 350001, China
Fuzhou, 350001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy and safety of cetuximab-irinotecan rechallenge versus regorafenib in ras wild-type metastatic colorectal cancer: a single-center exploratory randomized trial.
Journal: BMC cancer
Published: March 03, 2026
PRSS22 as a novel prognostic and immune regulatory biomarker in PanCancer multiomics analysis.
Journal: Scientific reports
Published: March 27, 2025
Predictable regulation of gut microbiome in immunotherapeutic efficacy of gastric cancer.
Journal: Genes and immunity
Published: May 17, 2024
Construction of a nomogram with IrAE and clinic character to predict the survival of advanced G/GEJ adenocarcinoma patients undergoing anti-PD-1 treatment.
Journal: Frontiers in immunology
Published: May 13, 2024
A two-stage maintenance trial of cetuximab-based treatment in RAS and BRAF wild-type unresectable metastatic colorectal cancer: a retrospective real-world study.
Journal: Frontiers in oncology
Published: April 29, 2024
New Rofecoxib-Based Mechanochromic Luminescent Materials and Investigations on Their Aggregation-Induced Emission, Acidochromism, and LD-Specific Bioimaging.
Journal: The journal of physical chemistry. B
Published: February 21, 2022
Achieving Molecular Fluorescent Conversion from Aggregation-Caused Quenching to Aggregation-Induced Emission by Positional Isomerization.
Journal: Molecules (Basel, Switzerland)
Published: December 08, 2021
Cetuximab Maintenance Therapy in Patients with Unresectable Wild-Type RAS and BRAF Metastatic Colorectal Cancer: A Single-Institute Prospective Study.
Journal: Advances in therapy
Published: March 05, 2020
Last Updated: 09/26/2026